- • Apply increased knowledge to treat hematopoietic stem cell transplantation patients more effectively
- • Evaluate pre-clinical and clinical studies that use cord blood for regenerative medicine purposes
- • Summarize reduced-intensity conditioning regimens and their role in treating patients who are older and/or more frail
- • Determine the indications for, and effectiveness of, double-unit cord blood transplants
- • Describe methods of ex-vivo expansion of progenitor cells derived from cord blood
- • Evaluate methods to improve engraftment of cord blood stem cells
- • Summarize current regulatory issues relevant to cord blood banking
- • Recognize the value of adoptive immune therapy for management of post-transplant viral infections
This live activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Nebraska Medical Center, Center for Continuing Education and the Cord Blood Forum.
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 22.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
BloodSource is approved by the California Board of Registered Nursing, provider number 03604, as a provider of continuing nursing education programs.
Medical Technologists/Clinical Laboratory Scientists
BloodSource is an approved provider of Continuing Education in clinical laboratory sciences, approved by the California Department of Health Services, provider number 0030.